Obesity is one of the most prevalent nutritional diseases, associated with chronic morbidity and mortality. Persuasive evidence indicates a striking association between obesity and incidence of common neoplasms, such as those of the esophagus, endometrium, kidney and breast in post menopause women, prostate in men, in addition to colon, rectum and bladder. Such an association has been supported by clinical and laboratory experiments on humans and animals, respectively. The findings have revealed that obesity and increased body fatness, in general and visceral adiposity, in particular, increase the vulnerability to develop different cancers. Although the impact of obesity in cancer progression differs according to the type of cancer, all the obesity-related cancers are centered around body adiposity. This review highlights the different hormonal, biochemical and molecular changes that might be involved in obesity-related cancers. Increased serum insulin, insulin-like growth factor, steroids "sex hormones" and the disturbances in adiponectin and leptin hormones are included. Biochemical and metabolic changes that mediate obesity-related carcinogenesis involving elevated oxidative stress and inflammation levels in the body and the concomitant increment in circulatory proinflammatory cytokines are discussed.